Bruno Sangro - Concepedia

Author

Bruno Sangro

Also Known As

B SANGRO, B Sangro, B. Sangro, B., Sangro, BRUNO SANGRO, Bernhard Scheiner, Bruno Sangro, Bruno Sangro Gómez-Acebo, Carlos Huertas, Geert Maleux

811

Publications

47.9K

Citations

H-Index

184

Concepts

All Affiliations

Clinica Universidad de Navarra Universidad de Navarra Centro de Investigación Biomédica en Red de Enfermedades Hepáticas y Digestivas Centro de Investigación Biomédica en Red Navarre Institute of Health Research

About

Bruno Sangro is an author at Clinica Universidad de Navarra specializing in medicine, hepatology, and oncology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	56	126	17.4K
2	Health Sciences	39	60	11.3K
3	Engineering	5	5	318
4	Natural Sciences	2	2	124
5	Anatomy	1	1	64

Bruno Sangro

241

Publications

31.9K

Citations

H-Index

Page 1

	Year	Citations
Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial Anthony B. El-Khoueiry, Bruno Sangro, Thomas Yau, The Lancet HepatologyMedicineExpansion TrialLiver CancerAdvanced Hepatocellular Carcinoma	2017	4.2K
Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade Philip J. Johnson, Sarah Berhane, Chiaki Kagebayashi, Journal of Clinical Oncology	2014	2.6K
Tremelimumab plus Durvalumab in Unresectable Hepatocellular Carcinoma Ghassan K. Abou‐Alfa, George Lau, Masatoshi Kudo, NEJM Evidence	2022	1.3K
Efficacy and Safety of Nivolumab Plus Ipilimumab in Patients With Advanced Hepatocellular Carcinoma Previously Treated With Sorafenib Thomas Yau, Yoon‐Koo Kang, Tae‐You Kim, JAMA Oncology	2020	1.2K
Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up Arndt Vogel, Andrés Cervantes, Ian Chau, Annals of Oncology HepatologyMedicineHistopathologyLiver DiseaseLiver Cancer	2018	1K
Unexpected high rate of early tumor recurrence in patients with HCV-related HCC undergoing interferon-free therapy María Reig, Zoe Mariñó, Christie Perelló, Journal of Hepatology HepatologyHepatitis CHcv-related HccViral HepatitisHigh Rate	2016	1K
A clinical trial of CTLA-4 blockade with tremelimumab in patients with hepatocellular carcinoma and chronic hepatitis C Bruno Sangro, Carlos Gómez-Martín, Manuel de la Mata, Journal of Hepatology HepatologyViral HepatitisMedicineImmunologyPathology	2013	977
Survival after Yttrium-90 resin microsphere radioembolization of hepatocellular carcinoma across Barcelona clinic liver cancer stages: A European evaluation Bruno Sangro, L Carpanese, Roberto Cianni, Hepatology	2011	648
CheckMate 459: A randomized, multi-center phase III study of nivolumab (NIVO) vs sorafenib (SOR) as first-line (1L) treatment in patients (pts) with advanced hepatocellular carcinoma (aHCC) Thomas Yau, J.W. Park, Richard S. Finn, Annals of Oncology HepatologyMedicineCheckmate 459Liver CancerAdvanced Hepatocellular Carcinoma	2019	639
Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines Arndt Vogel, Erika Martinelli, Arndt Vogel, Annals of Oncology Surgical OncologyHepatologyMedicineCancer ManagementTreatment Recommendations	2021	436

Page 1